SB 2748 amends the Mississippi Medical Cannabis Act in three main areas. First, it revises the Mississippi Medical Cannabis Equivalency Unit (MMCEU) so that one unit is treated as 3.5 grams of flower, one gram of total THC in a concentrate, or one gram of total THC in an infused product. Second, it expands access to medical cannabis certification by allowing a written certification to be issued after a telemedicine evaluation for patients who are homebound or bedbound, so long as another practitioner with a bona fide practitioner-patient relationship has certified that status. Third, it changes local government review timing by prohibiting applicants for a medical cannabis establishment license from seeking county or municipal zoning or permitting action until after they have received the state license.
The bill also preserves and restates much of the existing framework for qualifying patients, practitioners, caregivers, dispensaries, and other licensed cannabis businesses. It keeps the requirement that patients have a debilitating medical condition, a written certification, and a registry identification card, and it maintains the six-month follow-up visit requirement and practitioner continuing-education rules. Local governments may still regulate the time, place, and manner of medical cannabis operations, impose reasonable local licensing fees, and enforce setback rules, but they may not ban dispensaries outright or make their operation impracticable. The bill takes effect July 1, 2025.
In practical terms, the bill affects patients, healthcare practitioners, medical cannabis businesses, and local governments. For patients who are unable to travel, it creates a narrower telemedicine pathway to obtain certification. For businesses, it clarifies the sequencing of state licensing before local zoning or permitting applications, which may reduce premature local filings and related administrative disputes. For regulators, it reinforces the roles of the Mississippi Department of Health and the Mississippi Department of Revenue in licensing and oversight.
The general sentiment reflected in the voting history appears broadly favorable. The Senate passed the bill 40-11 after amendment, and the House passed it 108-7, indicating substantial bipartisan support despite some opposition. No committee transcript was provided, so the record does not show detailed floor or committee arguments, but the strong margins suggest the bill was viewed as a practical update to the medical cannabis program rather than a major policy reversal.
The main points of contention likely center on the telemedicine certification change and the local permitting restriction. Supporters would likely view the telemedicine provision as improving access for seriously ill or immobile patients, while critics may worry about loosening safeguards around medical cannabis certification. Local governments and some opponents may also object to limiting when applicants can seek zoning or permitting approvals, since it reduces local discretion early in the process. The bill’s overall structure, however, suggests a compromise approach that expands access while keeping the existing licensing and zoning framework intact.
SB 2748 amends Sections 41-137-3, 41-137-5, and 41-137-37 of the Mississippi Code within the Mississippi Medical Cannabis Act. It changes the statutory equivalency unit used to measure medical cannabis products, adds a telemedicine-based certification option for homebound or bedbound patients, and delays local zoning or permitting applications until after a state medical cannabis establishment license is issued. The bill leaves the broader licensing, patient eligibility, and local setback rules in place, while clarifying the respective roles of MDOH and MDOR.
The bill appears to have received generally favorable treatment in both chambers, as shown by the 40-11 Senate passage and the 108-7 House passage. Those margins suggest broad support for the bill’s access and administrative changes, even though some members opposed it. Because no committee transcript is available, the record does not identify specific floor arguments, but the voting history indicates the bill was not especially controversial overall.
Likely areas of disagreement are the telemedicine certification provision and the restriction on local zoning/permitting applications before state licensure. Supporters likely favored the telemedicine change as a way to help homebound or bedbound patients obtain medical cannabis certification without an in-person visit, while opponents may have viewed it as a relaxation of medical oversight. Local governments may also have concerns about the bill’s sequencing rule, which limits their ability to process zoning or permitting requests before a business secures a state license. The bill otherwise preserves existing local authority over time, place, and manner regulations and setback requirements, which may have helped reduce opposition.